Sign up
Pharma Capital

Former Callitas Health CEO Gary Thompson passes away after battle with cancer

James Thompson took over the reins of the Cincinnati-based health and wellness company from his uncle earlier this year
Gary Thompson
Former Callitas Health CEO Gary Thompson was very well regarded in the pharmaceutical industry

Cincinnati-based health and wellness company Callitas Health Inc (CSE:LILY, OTCQB:MPHMF, OTCMKTS: MPHMF) announced Friday that former CEO Gary A Thompson died after a long battle with cancer.

Thompson, who died Tuesday, was a pharmaceutical industry veteran with a career spanning over three decades. He worked with pharmaceutical giants and startups. He served as vice president of sales for Cigna Healthcare (NYSE:CI) before taking over the reins of M Pharmaceutical Inc and later Callitas Health. Thompson was a graduate of Northern Kentucky University, with a BS in Kinesiology.

Callitas Health CEO James Thompson, took over the mantle from his uncle, Gary, earlier this year.

“Gary was a larger-than-life figure who brought his remarkable passion, experience and energy to Callitas Health and he will be greatly missed,” said Callitas Board member William Rodgers.

Callitas Health, which is now spearheaded by the second generation of Thompsons, is a well-diversified company. It has a nimble strategy focused on getting quick revenues from mass-appeal over-the-counter products and a more long-term blockbuster pipeline. It is active across five silos: OTC sexual health & wellness, prescriptions for female sexual health, weight management, cannabis delivery technologies and orphan drugs.

Contact Uttara Choudhury at [email protected]

Follow her on Twitter@UttaraProactive 

View full LILY profile View Profile
View All

Related Articles

© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.